Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,666   1.18  Index Moved Down -0.07%
GILD AMGN BIIB CELG World Allocation Heavy Metals Electronics Investing 
United States GSPC USD ...  |  Investing Toolset


Processing
Collecting data for NOV and LLY ...

Asset Comparison and Correlation

    
Investment horizon: 
  30 Days    Login   to change
 
 National Oilwell Varco Inc.  vs   Eli Lilly and Company
 Compare Fundamentals  
Daily Returns (%)
NOV   LLY   
 
Considering 30-days investment horizon, National Oilwell Varco Inc is expected to generate 0.91 times more return on investment than Eli Lilly. However, National Oilwell Varco Inc is 1.09 times less risky than Eli Lilly. It trades about 0.29 of its potential returns per unit of risk. Eli Lilly and Company is currently generating about -0.15 per unit of risk. If you would invest  6,620  in National Oilwell Varco Inc on April 21, 2013 and sell it today you would earn a total of  397.00  from holding National Oilwell Varco Inc or generate 6.0% return on investment over 30 days.

Diversification

Good diversification
Overlapping area represents amount of risk that can be diversified away by holding National Oilwell Varco Inc. and Eli Lilly and Company in the same portfolio assuming nothing else is changed

Correlation Coefficient

-0.09
Parameters
Time Period1 Month [change]
DirectionNegative NOV Moved Down vs LLY
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns
Follow Correlation between NOV and LLY with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Correlation between NOV and LLY to your reader
 
Share Correlation between NOV and LLY 
Find Opportunities
 
Predicted Return Density
 
Returns   
NOV   LLY   

National Oilwell Varco Inc

 
    
National
Performance
15
Out Of
100
Over 30
Days
85% of all equities and portfolios perform better than National Oilwell Varco Inc. Compared with the overall equity markets, risk-adjusted returns on investments in National Oilwell Varco Inc are ranked lower than 15 (%) of all global equities and portfolios over the last 30 days.
    

Match ups for National

Schlumberger Limited vs. National Oilwell Varco Inc
Halliburton Company vs. National Oilwell Varco Inc
Baker Hughes Incorporated vs. National Oilwell Varco Inc
Cameron International Corporation vs. National Oilwell Varco Inc
FMC Technologies Inc vs. National Oilwell Varco Inc
Weatherford International Ltd vs. National Oilwell Varco Inc
Core Laboratories NV vs. National Oilwell Varco Inc
Oceaneering International Inc vs. National Oilwell Varco Inc
MDU Resources Group Inc vs. National Oilwell Varco Inc
  

Eli Lilly and Company

 
    
Eli Lilly
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Eli Lilly and Company has generated negative risk-adjusted returns adding no value to investors with long positions.
    

Match ups for Eli Lilly

Johnson Johnson vs. Eli Lilly and Company
Pfizer Inc vs. Eli Lilly and Company
Novartis AG vs. Eli Lilly and Company
Sanofi vs. Eli Lilly and Company
Merck Co Inc vs. Eli Lilly and Company
GlaxoSmithKline plc vs. Eli Lilly and Company
BristolMyers Squibb Company vs. Eli Lilly and Company
AstraZeneca PLC vs. Eli Lilly and Company
Impax Laboratories Inc vs. Eli Lilly and Company


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium